MENU
HROW
AS OF
Feb 4, 04:23 PM (EDT)
Price
$47.19
Change
-$0.00 (-0.00%)
Capitalization
1.75B
49 days until earnings call
Intraday BUY SELL Signals
+Compare
HROW
Stock ticker: NASDAQ
AS OF
Feb 4, 04:23 PM (EDT)
Price
$47.19
Change
-$0.00 (-0.00%)
Capitalization
1.75B

HROW Harrow Forecast, Technical & Fundamental Analysis

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U... Show more

HROW
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for HROW with price predictions
Feb 03, 2026

Momentum Indicator for HROW turns negative, indicating new downward trend

HROW saw its Momentum Indicator move below the 0 level on January 09, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned negative. In of the 81 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for HROW turned negative on January 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for HROW crossed bearishly below the 50-day moving average on January 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HROW declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

HROW broke above its upper Bollinger Band on January 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HROW's RSI Indicator exited the oversold zone, of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where HROW's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

HROW moved above its 50-day moving average on February 03, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where HROW advanced for three days, in of 287 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 223 cases where HROW Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. HROW’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (37.175) is normal, around the industry mean (29.792). P/E Ratio (0.000) is within average values for comparable stocks, (74.095). HROW's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.035). HROW has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (6.863) is also within normal values, averaging (116.680).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
HROW
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

HROW is expected to report earnings to rise 17.61% to 38 cents per share on March 25

Harrow HROW Stock Earnings Reports
Q4'25
Est.
$0.39
Q3'25
Beat
by $0.09
Q2'25
Beat
by $0.23
Q1'25
Missed
by $0.56
Q4'24
Beat
by $0.11
The last earnings report on November 10 showed earnings per share of 33 cents, beating the estimate of 23 cents. With 60.69K shares outstanding, the current market capitalization sits at 1.75B.
A.I. Advisor
published General Information

General Information

a pharmaceutical company

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
102 Woodmont Boulevard
Phone
+1 615 733-4730
Employees
315
Web
https://www.harrow.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OSCCX20.910.07
+0.34%
Invesco Main Street Small Cap C
EPSRX25.670.07
+0.27%
NYLI Epoch Global Equity Yield Class R6
DBOZX24.61-0.09
-0.36%
BNY Mellon Balanced Opportunity Z
PLFMX32.81-0.28
-0.85%
Principal Large Cap S&P 500 Index R3
MLMAX23.96-0.29
-1.20%
Morgan Stanley Instl Global Core A

HROW and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HROW has been loosely correlated with TKNO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if HROW jumps, then TKNO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
+5.10%
TKNO - HROW
35%
Loosely correlated
+2.95%
AMRX - HROW
34%
Loosely correlated
+0.42%
AMLX - HROW
33%
Loosely correlated
-1.23%
VTRS - HROW
32%
Poorly correlated
N/A
AQST - HROW
29%
Poorly correlated
N/A
More

Groups containing HROW

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HROW
1D Price
Change %
HROW100%
+5.10%
Pharmaceuticals: Generic
industry (214 stocks)
22%
Poorly correlated
-0.59%